Antibe Therapeutics Stock Price on June 4, 2024

ATBPF Stock  USD 0.22  0.00  0.00%   
If you're considering investing in Antibe Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Antibe Therapeutics stands at 0.22, as last reported on the 4th of December, with the highest price reaching 0.22 and the lowest price hitting 0.22 during the day. We have found three technical indicators for Antibe Therapeutics, which you can use to evaluate the volatility of the firm.
  
Antibe Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ATBPF
Based on monthly moving average Antibe Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Antibe Therapeutics by adding Antibe Therapeutics to a well-diversified portfolio.

Antibe Therapeutics Valuation on June 4, 2024

It is possible to determine the worth of Antibe Therapeutics on a given historical date. On June 4, 2024 Antibe was worth 0.22 at the beginning of the trading date compared to the closed value of 0.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Antibe Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find Antibe Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Antibe Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Antibe Therapeutics' related companies.
 Open High Low Close Volume
  0.22    0.22    0.22    0.22    1.00  
06/04/2024
  0.22    0.22    0.22    0.22    1.00  
  0.22    0.22    0.22    0.22    1.00  
Backtest Antibe Therapeutics  |  Antibe Therapeutics History  |  Antibe Therapeutics Valuation   PreviousNext  
Open Value
0.22
0.22
Closing Value
0.22
Upside

Antibe Therapeutics Trading Date Momentum on June 4, 2024

On June 05 2024 Antibe Therapeutics was traded for  0.22  at the closing time. The highest daily price throughout the period was 0.22  and the lowest price was  0.22 . There was no trading activity during the period 1.0. Lack of trading volume on 06/05/2024 did not affect price variability. The overall trading delta to current closing price is 0.00% .

Antibe Therapeutics Fundamentals Correlations and Trends

By evaluating Antibe Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Antibe Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Antibe financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Antibe Therapeutics Pink Sheet history

Antibe Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Antibe is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Antibe Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Antibe Therapeutics stock prices may prove useful in developing a viable investing in Antibe Therapeutics
Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. Antibe Therapeutics Inc. was incorporated in 2009 and is headquartered in Toronto, Canada. Antibe Therapeutics is traded on OTC Exchange in the United States.

Antibe Therapeutics Pink Sheet Technical Analysis

Antibe Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Antibe Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Antibe Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Antibe Therapeutics Period Price Range

Low
December 4, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Antibe Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Antibe Therapeutics December 4, 2024 Market Strength

Market strength indicators help investors to evaluate how Antibe Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Antibe Therapeutics shares will generate the highest return on investment. By undertsting and applying Antibe Therapeutics pink sheet market strength indicators, traders can identify Antibe Therapeutics entry and exit signals to maximize returns

Complementary Tools for Antibe Pink Sheet analysis

When running Antibe Therapeutics' price analysis, check to measure Antibe Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antibe Therapeutics is operating at the current time. Most of Antibe Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antibe Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antibe Therapeutics' price. Additionally, you may evaluate how the addition of Antibe Therapeutics to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stocks Directory
Find actively traded stocks across global markets